Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
IL-12 from endogenous cDC1, and not vaccine DC, is required for Th1 induction
DiyaaElDin Ashour, Panagiota Arampatzi, Vladimir Pavlovic, Konrad U. Förstner, Tsuneyasu Kaisho, Andreas Beilhack, Florian Erhard, Manfred B. Lutz
DiyaaElDin Ashour, Panagiota Arampatzi, Vladimir Pavlovic, Konrad U. Förstner, Tsuneyasu Kaisho, Andreas Beilhack, Florian Erhard, Manfred B. Lutz
View: Text | PDF
Research Article Immunology Vaccines

IL-12 from endogenous cDC1, and not vaccine DC, is required for Th1 induction

  • Text
  • PDF
Abstract

Success of DC vaccines relies on the quality of antigen presentation, costimulation, lymph node migration, and the release of IL-12, in case of Th1 priming. Here, we provide evidence for interaction between the injected vaccine DCs with endogenous lymph node–resident DCs for Th1 induction. While migration of the injected DCs was essential for antigen delivery to the lymph node, the injected DCs contributed only partially to Th0 priming and were unable to instruct Th1 generation. Instead, we provide evidence that the lymph node–resident XCR1+ DCs are activated by the injected DCs to present the cognate antigen and release IL-12 for Th1 polarization. The timing of interactions in the draining lymph nodes appeared step-wise as (a) injected DCs with cognate T cells, (b) injected DCs with bystander DCs, and (c) bystander DCs with T cells. The transcriptome of the bystander DCs showed a downregulation of Treg- and Th2/Th9-inducing genes and self-antigen presentation, as well as upregulation of MHC class II and genes required for Th1 instruction. Together, these data show that injected mature lymph node migratory DCs direct T cell priming and bystander DC activation, but not Th1 polarization, which is mediated by endogenous IL-12p70+XCR1+ resident bystander DCs. Our results are of importance for clinical DC-based vaccinations against tumors where endogenous DCs may be functionally impaired by chemotherapy.

Authors

DiyaaElDin Ashour, Panagiota Arampatzi, Vladimir Pavlovic, Konrad U. Förstner, Tsuneyasu Kaisho, Andreas Beilhack, Florian Erhard, Manfred B. Lutz

×

Figure 4

YFP+XCR1+ DCs interact with injected DCs and antigen-specific T cells at later time points.

Options: View larger image (or click on image) Download as PowerPoint
YFP+XCR1+ DCs interact with injected DCs and antigen-specific T cells at...
(A) Representative immunofluorescence microscopy images of whole popliteal lymph nodes sections (upper row) and magnification of the T cell area after of OT-II+Thy1.1+ T cell injection (red) + CTV-labeled Il12a–/– OVA-LPS/DC s.c. injection (yellow) into IL-12p40–YFP mice (green cells) (24, 48, or 72 hours after injection). White arrowheads point to the points of interaction between injected yellow DCs and YFP endogenous green DCs. (B) Graphs showing number of OT-II+Thy1.1+ T cells, CTV-labeled OVA-LPS/DC, and YFP+ endogenous DCs/popliteal lymph node cut 24, 58, 72 hours after DC injection. (C) Graphs showing the relative distance of CD11b+ cells, XCR1+ cells, and YFP+ cells to CTV-labeled OVA-LPS/DC in the peripheral lymph nodes 24, 48, or 72 hours after DC injection. Graphs showing the relative distance of OT-II+Thy1.1+ T cells to CTV-labeled OVA-LPS/DC or to YFP+ endogenous DCs in the peripheral lymph nodes 24, 48, or 72 hours after DC injection. Green arrow indicates the distance shift at 48 and 72 hours compared with 24 hours. Data are representative of 2 independent experiments analyzing at least 4 mice per group. One-way ANOVA with multiple comparisons and Tukey’s post hoc test; ***P < 0.0001, **P < 0.001, *P < 0.05. (D) Model about the time kinetics of cellular interactions suggested by the microscopic analyses.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts